Literature DB >> 29274415

The activation and function of IL-36γ in neutrophilic inflammation in chronic rhinosinusitis.

Hai Wang1, Zhi-Yong Li2, Wen-Xiu Jiang1, Bo Liao1, Guan-Ting Zhai1, Nan Wang1, Zhen Zhen3, Jian-Wen Ruan1, Xiao-Bo Long1, Heng Wang1, Wei-Hong Liu4, Geng-Tian Liang5, Wei-Min Xu6, Atsushi Kato7, Zheng Liu1.   

Abstract

BACKGROUND: Although increased accumulation of neutrophils has been noted in chronic rhinosinusitis (CRS), the function and regulation of neutrophils in CRS are largely unknown. IL-36 family cytokines may play an important role in neutrophilic inflammation.
OBJECTIVE: This study sought to investigate the expression and function of IL-36 cytokines in CRS.
METHODS: Quantitative RT-PCR, immunohistochemistry, immunofluorescence, and ELISA were used to investigate the expression of IL-36 cytokines and IL-36 receptor (IL-36R) in sinonasal mucosa. The expression of IL-36R on neutrophils in polyps and blood was measured by flow cytometry. Purified blood neutrophils were cultured to investigate the regulation of IL-36R expression. The cleavage of IL-36γ was detected by Western blotting. Dispersed nasal polyp cells were treated with IL-36γ with or without elastase inhibitor and dexamethasone.
RESULTS: Neutrophil infiltration and expression of IL-36 cytokines and IL-36R were upregulated in both CRS with and without nasal polyps. IL-36γ was the most abundant isoform and mainly expressed by epithelial cells in CRS. Neutrophils were the principal IL-36R+ cell type in polyps. IL-36R expression was almost absent in blood neutrophils and upregulated by IL-6, IL-1β, and Dermatophagoides pteronyssinus group 1. Elastase activity was increased in polyps and degraded full-length IL-36γ. Consistently, the levels of cleaved IL-36γ were increased in polyps. Full-length IL-36γ promoted the production of matrix metalloproteinase 9; IL-17A; and chemokine (C-X-C motif) ligands 1, 2, and 8 from dispersed nasal polyp cells, which was abolished by elastase inhibitor. The proinflammatory effect of IL-36γ was not suppressed by dexamethasone.
CONCLUSIONS: Increased production and activation of IL-36γ may act on neutrophils and further exaggerate neutrophilic inflammation in CRS.
Copyright © 2017 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Activate; IL-17; IL-36; chronic rhinosinusitis; elastase; nasal polyps; neutrophil

Mesh:

Substances:

Year:  2017        PMID: 29274415     DOI: 10.1016/j.jaci.2017.12.972

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  27 in total

Review 1.  Pathophysiologic mechanisms of chronic rhinosinusitis and their roles in emerging disease endotypes.

Authors:  Ping-Ping Cao; Zhi-Chao Wang; Robert P Schleimer; Zheng Liu
Journal:  Ann Allergy Asthma Immunol       Date:  2018-10-13       Impact factor: 6.347

2.  Expression of Apoptosis-Related Biomarkers in Inflamed Nasal Sinus Epithelium of Patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)-Evaluation at mRNA and miRNA Levels.

Authors:  Monika Morawska-Kochman; Agnieszka Śmieszek; Klaudia Marcinkowska; Krzysztof Mariusz Marycz; Kamil Nelke; Krzysztof Zub; Tomasz Zatoński; Marek Bochnia
Journal:  Biomedicines       Date:  2022-06-13

Review 3.  IL-36 in chronic inflammation and fibrosis - bridging the gap?

Authors:  Michael Elias; Shuai Zhao; Hongnga T Le; Jie Wang; Markus F Neurath; Clemens Neufert; Claudio Fiocchi; Florian Rieder
Journal:  J Clin Invest       Date:  2021-01-19       Impact factor: 14.808

4.  The Protective Role of IL-36/IL-36R Signal in Con A-Induced Acute Hepatitis.

Authors:  Xiaofang Wang; Yuejin Liang; Hui Wang; Biao Zhang; Lynn Soong; Jiyang Cai; Panpan Yi; Xuegong Fan; Jiaren Sun
Journal:  J Immunol       Date:  2022-01-19       Impact factor: 5.422

Review 5.  Endotypes of chronic rhinosinusitis: Relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches.

Authors:  Atsushi Kato; Anju T Peters; Whitney W Stevens; Robert P Schleimer; Bruce K Tan; Robert C Kern
Journal:  Allergy       Date:  2021-09-15       Impact factor: 14.710

Review 6.  Rethinking neutrophils and eosinophils in chronic rhinosinusitis.

Authors:  Tim Delemarre; Bruce S Bochner; Hans-Uwe Simon; Claus Bachert
Journal:  J Allergy Clin Immunol       Date:  2021-04-21       Impact factor: 14.290

Review 7.  IL-36 cytokines and gut immunity.

Authors:  Vu L Ngo; Michal Kuczma; Estera Maxim; Timothy L Denning
Journal:  Immunology       Date:  2021-02-24       Impact factor: 7.215

Review 8.  Recent advances in understanding chronic rhinosinusitis endotypes.

Authors:  Eric F Succar; Justin H Turner
Journal:  F1000Res       Date:  2018-12-07

Review 9.  The Role of IL-36 in Infectious Diseases: Potential Target for COVID-19?

Authors:  Xiaofang Wang; Panpan Yi; Yuejin Liang
Journal:  Front Immunol       Date:  2021-05-13       Impact factor: 7.561

10.  Two-Track Medical Treatment Strategy According to the Clinical Scoring System for Chronic Rhinosinusitis.

Authors:  Dong Kyu Kim; Seong Il Kang; Il Gyu Kong; Young Hoon Cho; Seul Ki Song; Se Jin Hyun; Sung Dong Cho; Sang Yoon Han; Seong Ho Cho; Dae Woo Kim
Journal:  Allergy Asthma Immunol Res       Date:  2018-09       Impact factor: 5.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.